Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer-Reference-Cited by-同舟云学术

Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer

Published:2016-09 Issue:3 Volume:70 Page:438-444
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Fizazi Karim,Chi Kim N.,de Bono Johann S.,Gomella Leonard G.,Miller Kurt,Rathkopf Dana E.,Ryan Charles J.,Scher Howard I.,Shore Neal D.,De Porre Peter,Londhe Anil,McGowan Tracy,Pelhivanov Nonko,Charnas Robert,Todd Mary B.,Montgomery Bruce

Publisher

Elsevier BV

Subject

Urology

Reference12 articles.

1. Pharmacology of novel steroidal inhibitors of cytochrome P450 (17) alpha (17 alpha-hydroxylase/C17-20 lyase);Barrie;J Steroid Biochem Mol Biol,1994

2. Targeting continued androgen receptor signaling in prostate cancer;Massard;Clin Cancer Res,2011

3. Novel steroidal inhibitors of human cytochrome P45017 alpha (17 alpha-hydroxylase-C17,20-lyase): potential agents for the treatment of prostatic cancer;Potter;J Med Chem,1995

4. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N Engl J Med,2011

5. Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study;Fizazi;Lancet Oncol,2012

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A net-work meta-analysis of the cardiac safety for next-generation hormonal agents in treating castration-resistant prostate cancer: How to choose drugs appropriately?;Critical Reviews in Oncology/Hematology;2024-04

2. Risk of Metabolic and Cardiovascular Adverse Events With Abiraterone or Enzalutamide Among Men With Advanced Prostate Cancer;JNCI: Journal of the National Cancer Institute;2022-04-13

3. JC Polyoma Virus as a Possible Risk Factor for Prostate Cancer Development - Immunofluorescence and Molecular Based Case Control Study;Cancer Control;2022-01

4. The Effect of Corticosteroids on Prostate Cancer Outcome Following Treatment with Enzalutamide: A Multivariate Analysis of the Phase III AFFIRM Trial;Clinical Cancer Research;2021-12-29

5. Preserving Well-being in Patients With Advanced and Late Prostate Cancer;Urology;2021-09